A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302and CYP Substrates in Health ...
A Single-center, Open-label, Single-arm, Fixed-sequence Study to Evaluate the Pharmacokinetic Effects of SHR0302Tablets on Substrates of CYP3A4, CYP2C8, CYP2C9, CYP2C19 in Healthy Volunteers A Single-center, Open-label, Single-arm, Fixed-sequence Study to Evaluate the Pharmacokinetic Effect ...
Study on the Pharmacokinetic Effect of Itraconazole on SHR0302Tablets in Healthy Subjects
Study on the Pharmacokinetic Effects of Single-centered, Open, Single-arm, Fixed-sequence Itraconazole on SHR0302Tablets in Healthy Subjects Study on the Pharmacokinetic Effects of Single-centered, Open, Single-arm, Fixed-sequence Itraconazo ...
Study of SHR0302Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Assess the Safety and Efficacy of SHR0302 in Patients With Moderate to Severe Active Rheumatoid Arthritis Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Assess the Safety and E ...
A phase 3 Study to Evaluate the Efficacy and Safety of SHR0302 in Ulcerative Colitis.
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 for Induction, Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302for Induction, Maintenance T ...
Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification ...
Product Name: SHR0302tablets Product Code: SHR0302 INN or Proposed INN: SHR0302